Westport, CT, May 03, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) or (“BioSig” or 'the Company'), a medical technology company delivering unprecedented accuracy and precision to intra-cardiac signal visualization, today announced new appointments to its now fully constituted board of directors (the “Board”), which is comprised of a total of five (5) directors, three (3) of whom are classified as independent directors.

康涅狄格州西港，2024年5月3日（环球通讯社）--BioSig Technologies，Inc.（纳斯达克股票代码：BSGM）或（“BioSig”或“本公司”）是一家医疗技术公司，为心脏内信号可视化提供了前所未有的准确性和精确性，今天宣布了对其现已正式成立的董事会（“董事会”）的新任命，该董事会由五（5）名董事组成，其中三（3）名被列为独立董事。

The final compositions of the committees to the Board will be determined in the very near term. Commenting on the newly assembled Board, BioSig’s CEO, Mr. Anthony Amato stated, “The Company is proud to introduce its new members on our Board, which includes talented individuals with years of experience across a broad array of industries and professions.

董事会各委员会的最终组成将在近期内确定。BioSig首席执行官安东尼·阿马托（AnthonyAmato）先生在评论新组建的董事会时表示：“公司很自豪能在董事会中引入新成员，其中包括在各种行业和专业领域拥有多年经验的人才。

The Board is now compliant with the rules and regulations that govern the standards acceptable to major U.S. Exchanges, including three (3) highly qualified independent directors, and I am confident that our directors will uphold their strategic, financial, and managerial responsibilities to the Company.

董事会现在符合管理美国主要交易所可接受标准的规则和规定，包括三（3）名高素质的独立董事，我相信我们的董事会将履行其对公司的战略、财务和管理责任。

BioSig continues to realize important and meaningful progress and is working with great urgency to create lasting shareholder value.” Board Member #1, Anthony Amato Mr. Anthony Amato is a business leader and entrepreneurial thinker with an intuitive ability to rapidly assess challenges and identify growth opportunities.

BioSig继续取得重要而有意义的进展，并正在紧迫地努力创造持久的股东价值。”董事会成员安东尼·阿马托安东尼·阿马托先生是一位商业领袖和创业思想家，具有快速评估挑战和识别增长机会的直觉能力。

He quickly sees organizational vision and understands goals, taking appropriate ownership and action required to guide the team, achieving aggressive targets and performance levels. Mr. Amato has hands-on executive skills at engaging and influencing key stakeholders to not only grow business but also to optimize profits.

他迅速看到组织愿景并理解目标，采取适当的所有权和行动来指导团队，实现积极的目标和绩效水平。先生。Amato在吸引和影响关键利益相关者方面拥有实际的管理技能，不仅可以发展业务，还可以优化利润。

Mr. Amato founded InQuest Science in March 2017.

阿马托先生于2017年3月创立了InQuest Science。